Work

Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

Year: 2022

Type: article

Authors: Beverly Moy, R. Bryan Rumble, Lisa A. Carey, for the Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative Expert Panel

Institutions: Massachusetts General Hospital, American Society of Clinical Oncology, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4289784923

FWCI: 2.258

Cites: 3

Cited by: 30

Related to: 10